Erik Korevaar

Search results

• 2024

  Proton versus photon therapy for esophageal cancer – A trimodality strategy (PROTECT) NCT050555648: A multicenter international randomized phase III study of neoadjuvant proton versus photon chemoradiotherapy in locally advanced esophageal cancer

  The PROTECT consortium, Mortensen, H. R., Populaire, P., Hoffmann, L., Moeller, D. S., Appelt, A., Nafteux, P., Muijs, C. T., Grau, C., Hawkins, M. A., Troost, E. G. C., Defraene, G., Canters, R., Clarke, C. S., Weber, D. C., Korevaar, E. W., Haustermans, K., Nordsmark, M., Gebski, V. & Achiam, M. P. & 16 others, Markar, S. R., Radhakrishna, G., Berbee, M., Scartoni, D., Orlandi, E., Doyen, J., Gregoire, V., Crehange, G., Langendijk, J., Lorgelly, P., Blommenstein, H. M., Byskov, C. S., Ehmsen, M. L., Jensen, M. F., Freixas, G. V. & Bütoft, R., Jan-2024, In: Radiotherapy and Oncology. 190, 3 p., 109980.

  Research output: Contribution to journal › Editorial › Academic › peer-review

  Open Access

  File
  5 Citations (Scopus)

  292 Downloads (Pure)